Cas:33252-26-5 4-tert-butylpyridin-2-amine manufacturer & supplier

Chemical Name:4-tert-butylpyridin-2-amine

CAS.NO:33252-26-5

Synonyms:4-TERT-BUTYL-PYRIDIN-2-YLAMINE;2-amino-4-tert-butylpyridine;2-amino-4-t-butyl pyridine;2-AMINO-4-(TERT-BUTYL)PYRIDINE

Molecular Formula:C₉H₁₄N₂

Molecular Weight:150.22100

HS Code:2933399090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:39.64000

Exact Mass:150.11600

LogP:1.89140

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 4-TERT-BUTYL-PYRIDIN-2-YLAMINE chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-AMINO-4-(TERT-BUTYL)PYRIDINE physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-amino-4-t-butyl pyridine Use and application,2-AMINO-4-(TERT-BUTYL)PYRIDINE technical grade,usp/ep/jp grade.

Related News: It was not clear which inquiry – the company’s or the government’s – was launched first and to what extent the subjects coincide. However, as Reuters reported last month, based on three sources familiar with the matter, the Justice Department’s investigation into Lilly includes a review of alleged manufacturing irregularities and records-tampering. 4-tert-butylpyridin-2-amine manufacturer INSPIRE is a global, multi-center, randomized, controlled study to assess the efficacy and safety of IV rigosertib in higher-risk MDS (HR-MDS) patients who had progressed on, failed to respond to, or relapsed after previous treatment with a hypomethylating agent (HMA) within nine cycles over the course of one year after initiation of HMA treatment. 4-tert-butylpyridin-2-amine supplier It was not clear which inquiry – the company’s or the government’s – was launched first and to what extent the subjects coincide. However, as Reuters reported last month, based on three sources familiar with the matter, the Justice Department’s investigation into Lilly includes a review of alleged manufacturing irregularities and records-tampering. 4-tert-butylpyridin-2-amine vendor One source familiar with the matter told Reuters that the J&J doses are expected to be exported to other countries. The doses are already in vials and ready for use, the other source said. 4-tert-butylpyridin-2-amine factory INSPIRE is a global, multi-center, randomized, controlled study to assess the efficacy and safety of IV rigosertib in higher-risk MDS (HR-MDS) patients who had progressed on, failed to respond to, or relapsed after previous treatment with a hypomethylating agent (HMA) within nine cycles over the course of one year after initiation of HMA treatment.